razoxane has been researched along with Nasopharyngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, W; Doroshow, JH; Gandara, D; Groshen, S; Johnson, K; Lenz, HJ; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Yen, Y | 1 |
1 trial(s) available for razoxane and Nasopharyngeal Neoplasms
Article | Year |
---|---|
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cations; Chromatography, High Pressure Liquid; Cohort Studies; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms; Razoxane; Time Factors | 2001 |